
|Articles|August 14, 2018
CEO of Aerie Pharmaceuticals provides a brief company overview at OIS meeting
Advertisement
Vince Anido, Chairman & Chief Executive Officer of Aerie Pharmaceuticals, Inc., provides an update on the company's glaucoma drugs at the Ophthalmology Innovation Summit (OIS) meeting during the annual American Society of Retina Specialists (ASRS) conference in Vancouver, British Columbia, on July 20th, 2018.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
The Atrophy Advisor: An online tool to inform GA treatment decisions
2
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
3
FLORetina 2025: Updates on tinlarebant in adolescent Stargardt disease
4
Enhancing Durability and Fluid Control with Aflibercept 8 mg in Retinal Vascular Diseases
5








































